Cargando…

Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease

BACKGROUND AND OBJECTIVES: Short-chain fatty acids (SCFAs) are gut microbial metabolites that promote the disease process in a rodent model of Parkinson disease (PD), but fecal levels of SCFAs in patients with PD are reduced. Simultaneous assessments of fecal and plasma SCFA levels, and their interr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Szu-Ju, Chen, Chieh-Chang, Liao, Hsin-Yu, Lin, Ya-Ting, Wu, Yu-Wei, Liou, Jyh-Ming, Wu, Ming-Shiang, Kuo, Ching-Hua, Lin, Chin-Hsien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883514/ https://www.ncbi.nlm.nih.gov/pubmed/34996879 http://dx.doi.org/10.1212/WNL.0000000000013225

Ejemplares similares

Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease
por: Lin, Chin-Hsien, et al.
Publicado: (2019)

The interplay between Helicobacter pylori and gastrointestinal microbiota
por: Chen, Chieh-Chang, et al.
Publicado: (2021)

Toward population specific and personalized treatment of Helicobacter pylori infection
por: Liou, Jyh-Ming, et al.
Publicado: (2018)

Fecal microbiota transplantation and short‐chain fatty acids protected against cognitive dysfunction in a rat model of chronic cerebral hypoperfusion
por: Su, Shao‐Hua, et al.
Publicado: (2023)

Associations of gut microbiota, dietary intake, and serum short-chain fatty acids with fecal short-chain fatty acids
por: YAMAMURA, Ryodai, et al.
Publicado: (2019)

Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma
por: Kuo, Sung-Hsin, et al.
Publicado: (2022)

Association of fecal short-chain fatty acids with clinical severity and gut microbiota in essential tremor and its difference from Parkinson’s disease
por: Huang, Pei, et al.
Publicado: (2023)

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome
por: El‐Salhy, Magdy, et al.
Publicado: (2020)

Effects of Different Concentrations of Ganpu Tea on Fecal Microbiota and Short Chain Fatty Acids in Mice
por: Wang, Chen, et al.
Publicado: (2021)

Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
por: Lin, Chin-Hsien, et al.
Publicado: (2018)

Short- and Branched-Chain Fatty Acids as Fecal Markers for Microbiota Activity in Vegans and Omnivores
por: Trefflich, Iris, et al.
Publicado: (2021)

Effects of rye inclusion in dog food on fecal microbiota and short-chain fatty acids
por: Palmqvist, Hanna, et al.
Publicado: (2023)

The Association Between Fecal Short-Chain Fatty Acids, Gut Microbiota, and Visceral Fat in Monozygotic Twin Pairs
por: Yin, Xing-Qi, et al.
Publicado: (2022)

First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
por: Kuo, Sung-Hsin, et al.
Publicado: (2017)

Treatment of Refractory Helicobacter pylori Infection-Tailored or Empirical Therapy
por: Liou, Jyh-Ming, et al.
Publicado: (2022)

Fecal microbiota transplantation and short-chain fatty acids reduce sepsis mortality by remodeling antibiotic-induced gut microbiota disturbances
por: Lou, Xiran, et al.
Publicado: (2023)

Mass Eradication of Helicobacter pylori to Prevent Gastric Cancer: Theoretical and Practical Considerations
por: Lee, Yi-Chia, et al.
Publicado: (2016)

Associations of Plastic Bottle Exposure with Infant Fecal Microbiota, Short-Chain Fatty Acids, and Growth
por: Zhao, Heather Jianbo, et al.
Publicado: (2023)

Gut microenvironmental changes as a potential trigger in Parkinson’s disease through the gut–brain axis
por: Chen, Szu-Ju, et al.
Publicado: (2022)

Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles
por: Yang, Shieh-Yueh, et al.
Publicado: (2016)

Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
por: Lin, Chin-Hsien, et al.
Publicado: (2017)

Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation
por: Kuai, Xiao-yi, et al.
Publicado: (2021)

Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy
por: Chai, Lingxiong, et al.
Publicado: (2021)

Exploration of the relationship between gut microbiota and fecal microRNAs in patients with major depressive disorder
por: Chen, Hui-Mei, et al.
Publicado: (2022)

Effects of Sleeve Gastrectomy on Fecal Gut Microbiota and Short-Chain Fatty Acid Content in a Rat Model of Polycystic Ovary Syndrome
por: Lin, Wei, et al.
Publicado: (2021)

Fecal microbiota transplantation and replenishment of short-chain fatty acids protect against chronic cerebral hypoperfusion-induced colonic dysfunction by regulating gut microbiota, differentiation of Th17 cells, and mitochondrial energy metabolism
por: Su, Shao-Hua, et al.
Publicado: (2022)

2073: Fecal bile acids, fecal short-chain fatty acids and the intestinal microbiota in patients with irritable bowel syndrome (IBS) and control volunteers
por: Shin, Andrea, et al.
Publicado: (2018)

2103 Fecal bile acids, fecal short-chain fatty acids, and the intestinal microbiota in patients with irritable bowel syndrome (IBS) and control volunteers
por: Shin, Andrea, et al.
Publicado: (2018)

Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
por: Tsai, Kun-Feng, et al.
Publicado: (2017)

Combating multidrug-resistant Helicobacter pylori with moenomycin A in combination with clarithromycin or metronidazole
por: Tseng, Yen-Yu, et al.
Publicado: (2022)

Fecal short chain fatty acids modify therapeutic effects of sleeve gastrectomy
por: Shen, Chongrong, et al.
Publicado: (2023)

Parkinson’s disease patients’ short chain fatty acids production capacity after in vitro fecal fiber fermentation
por: Baert, Florence, et al.
Publicado: (2021)

Fecal microbiota transplantation therapy for Parkinson's disease: A preliminary study
por: Xue, Liu-Jun, et al.
Publicado: (2020)

Effects of Vigiis 101-LAB on a healthy population's gut microflora, peristalsis, immunity, and anti-oxidative capacity: A randomized, double-blind, placebo-controlled clinical study
por: Chen, Chien-Li, et al.
Publicado: (2020)

Short Chain Fatty Acids and Fecal Microbiota Abundance in Humans with Obesity: A Systematic Review and Meta-Analysis
por: Kim, Kyu Nam, et al.
Publicado: (2019)

Sex‐based differences in fecal short‐chain fatty acid and gut microbiota in irritable bowel syndrome patients
por: Sun, Qing Hua, et al.
Publicado: (2021)

Gut microbiota and fecal short chain fatty acids differ with adiposity and country of origin: The METS-Microbiome Study
por: Gilbert, Jack, et al.
Publicado: (2023)

Gut microbiota and fecal short chain fatty acids differ with adiposity and country of origin: The METS-Microbiome Study
por: Ecklu-Mensah, Gertrude, et al.
Publicado: (2023)

A newly developed solution for the preservation of short-chain fatty acids, bile acids, and microbiota in fecal specimens
por: Takagi, Tomohisa, et al.
Publicado: (2023)

Gut microbiota and fecal short chain fatty acids differ with adiposity and country of origin: the METS-microbiome study
por: Ecklu-Mensah, Gertrude, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mr0d8uajl4uj7r61su5pg8nk3o